Matches in Wikidata for { <http://www.wikidata.org/entity/Q91618300> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91618300 description "article scientifique publié en 2018" @default.
- Q91618300 description "artículu científicu espublizáu en payares de 2018" @default.
- Q91618300 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91618300 description "scientific article published on 01 November 2018" @default.
- Q91618300 description "wetenschappelijk artikel" @default.
- Q91618300 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q91618300 name "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 name "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 type Item @default.
- Q91618300 label "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 label "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 prefLabel "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 prefLabel "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 P1433 Q91618300-24039C90-DE7A-4A24-B35F-25B39913851E @default.
- Q91618300 P1476 Q91618300-0A9745FD-A9A3-49BB-B36B-159952B0B3FA @default.
- Q91618300 P2093 Q91618300-2B3454E6-28FD-4A59-A74B-E582EAB89DD1 @default.
- Q91618300 P2093 Q91618300-46C8970E-FD8B-4C94-ABA4-6CE9F0669199 @default.
- Q91618300 P304 Q91618300-D5226AF5-F8D5-4F70-A2C8-5C28B8D5B692 @default.
- Q91618300 P31 Q91618300-D8E13B4E-AFA3-4F19-9930-B71FDC2A9E28 @default.
- Q91618300 P356 Q91618300-1C053EE7-0A3A-4F15-9287-32C1AD29E5A0 @default.
- Q91618300 P433 Q91618300-5CA4F362-1D8E-4B7B-BA1B-3B707291BB7B @default.
- Q91618300 P478 Q91618300-311F19B4-CB02-4358-943B-64329AA986B2 @default.
- Q91618300 P50 Q91618300-38B0933D-EDD2-42AC-B6A0-08EF0A8DE24A @default.
- Q91618300 P50 Q91618300-3EEED5F5-C338-4F0D-9F0B-32B21F2D6945 @default.
- Q91618300 P50 Q91618300-D53EE25C-7160-4853-BFA0-D110FA0CF977 @default.
- Q91618300 P50 Q91618300-E3AA9952-4155-4D35-B9CE-35DE01F1B52F @default.
- Q91618300 P50 Q91618300-EC0B0E5B-597F-43D4-9DA3-640AA9ACFDDE @default.
- Q91618300 P577 Q91618300-CF5AC12B-7370-4102-AE30-8D34FB808807 @default.
- Q91618300 P698 Q91618300-D041E58F-5B05-40D6-9497-817189D76810 @default.
- Q91618300 P921 Q91618300-758717DF-81B7-4E32-BA48-29978AD9D01B @default.
- Q91618300 P356 JJY111 @default.
- Q91618300 P698 30239644 @default.
- Q91618300 P1433 Q15817379 @default.
- Q91618300 P1476 "Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease" @default.
- Q91618300 P2093 "Ann Gils" @default.
- Q91618300 P2093 "Gert Van Assche" @default.
- Q91618300 P304 "1316-1325" @default.
- Q91618300 P31 Q13442814 @default.
- Q91618300 P356 "10.1093/ECCO-JCC/JJY111" @default.
- Q91618300 P433 "11" @default.
- Q91618300 P478 "12" @default.
- Q91618300 P50 Q110729292 @default.
- Q91618300 P50 Q114416502 @default.
- Q91618300 P50 Q30247983 @default.
- Q91618300 P50 Q58428476 @default.
- Q91618300 P50 Q89598104 @default.
- Q91618300 P577 "2018-11-01T00:00:00Z" @default.
- Q91618300 P698 "30239644" @default.
- Q91618300 P921 Q917447 @default.